SFA Therapeutics
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Comparison of Otezla to SFA-002 to Placebo in Plaque Psoriasis Patients (NCT06863493) | SFA Therapeutics | 2025-06-01 |
| Study of SFA002 in Patients with Mild to Moderate Psoriasis Plaques (NCT05642182) | SFA Therapeutics | 2022-03-31 |
Track SFA Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.